Market makers cleaned out all the stop loss orders today cleaning up on another million shares at bargain prices. Leo will release phase 2b bottom line data on monday, mark this post. The man will also probably announce mechanics of the phase 3 trial. I think the delay is because the FDA would like to compare Brilacidin to the current drug of choice Vancomycin. If B can take on and out perform Vancomycin it would guarantee a Fast Track designation. Daptomycin is not the current drug of choice and people here forget to check the facts. Leo and Menon must go toe to toe in phase 3 with Vancomycin. They will beat V hands down...
Market Data 
Markets 
AI
